Reviews

Prevalence and maternal-fetal outcome among patients with gestational diabetes at Aminu Kano Teaching Hospital

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 11 September 2025
Accepted: 6 November 2025
Published: 18 August 2026
31
Views
13
Downloads

Authors

Gestational Diabetes Mellitus (GDM) is any degree of glucose intolerance with onset or first recognition during pregnancy. Women with GDM are at increased risk of adverse obstetric and perinatal outcome. The aim of this study is to review and determine the prevalence of GDM in Aminu Kano Teaching Hospital, Nigeria.

It is a retrospective study on women with GDM attending the antenatal clinic of Aminu Kano Teaching Hospital from January 2019 to December 2019. Patients with GDM were identified by getting their Oral Glucose Tolerance Test (OGTT) results from the register of chemical pathology laboratory, then their case folders were retrieved from the records department and their socio-demographic characteristics were filled into a proforma and analysed using the Statistical Package for Social Sciences (SPSS) version 23.

Results were presented using descriptive statistics (tables, charts and chi-square test). A total of 2416 clients attended antenatal clinic during the study period. 217 patients had an indication for OGTT which was done in chemical pathology lab of Aminu Kano Teaching Hospital. The OGTT result of 48 patients fell within the diagnostic value of GDM giving a prevalence of 2%. The peak age range was 31-35 years with a mean age of 31.9±4.61. Most - 23 (69.7%) - were Hausa by tribe with either secondary 17 (51.5%) or tertiary education 16 (48.5%), but mostly full-time house wives 16 (48.5%). In this study, the most common associated factor was family history of diabetes (27%), followed by those with a previous history of GDM (15%) then previous delivery of a macrosomic baby (12%) and associated medical condition (12%), then those with a history of sudden Intrauterine Fetal Demise (IUFD) (3%). There was a statistically significant difference between the obstetric outcome and the abnormality in blood sugar level.

The prevalence of GDM in this study is low but falls within the global range. The most common associated factor was family history of diabetes and there was a statistically significant association between the obstetric outcome and the abnormality in blood sugar level.

Downloads

Download data is not yet available.

Citations

1. World Health Organization (WHO). Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. 2013 Available from: https://www.ncbi.nlm.nih.gov/books/NBK169024/
2. Rodriguez BSQ, Mahdy H. Gestational Diabetes. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545196/
3. American Diabetes Association. Standards of medical care in diabetes - 2014. Diabetes Care 2014;37:S14-80. DOI: https://doi.org/10.2337/dc14-S014
4. Senat M, Deruelle P. Gestational diabetes mellitus. Gynecol Obstet Fertil 2016;44:244-7. DOI: https://doi.org/10.1016/j.gyobfe.2016.01.009
5. Lindsay RS, Mackin ST, Nelson SM. Gestational diabetes mellitus - right person, right treatment, right time? BMC Med 2017;15:163. DOI: https://doi.org/10.1186/s12916-017-0925-2
6. Wendland E, Torloni M, Falavigna M, et al. Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth 2012;12:23. DOI: https://doi.org/10.1186/1471-2393-12-23
7. Wong T, Ross G, Jalaludin B, Flack J. The clinical significance of overt diabetes in pregnancy. Diabet Med 2013;30:468-74. DOI: https://doi.org/10.1111/dme.12110
8. Spaight C, Gross J, Horsch A, Puder JJ. Gestational diabetes mellitus. Endocr Dev 2016;31:163-78. DOI: https://doi.org/10.1159/000439413
9. American College of Obstetricians and Gynecologists (ACOG). Practice bulletin no. 190: gestational diabetes mellitus. Obstet Gynecol 2018;131:49-64. DOI: https://doi.org/10.1097/AOG.0000000000002501
10. Muche AA, Olayemi OO, Gete YK. Prevalence and determinants of gestational diabetes mellitus in Africa based on the updated international diagnostic criteria: a systematic review and meta-analysis. Arch Public Heal 2019;77:1-20. DOI: https://doi.org/10.1186/s13690-019-0362-0
11. Macaulay S, Dunger D, Norris S. Gestational diabetes mellitus in Africa: a systematic review. PLoS One 2014;9. DOI: https://doi.org/10.1371/journal.pone.0097871
12. Erem C, Kuzu U, Deger O, Can G. Prevalence of gestational diabetes mellitus and associated risk factors in Turkish women: the Trabzon GDM study. Arch Med Sci 2015;11:724-35. DOI: https://doi.org/10.5114/aoms.2015.53291
13. Hunsberger M, Rosenberg K, Donatelle R. Racial/ethnic disparities in gestational diabetes mellitus: findings from a population-based survey. Women’s Health Issues 2010;20:323-8. DOI: https://doi.org/10.1016/j.whi.2010.06.003
14. Farrar D, Duley L, Dowswell T, Lawlor D. Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database Syst Rev 2017;8:CD007122. DOI: https://doi.org/10.1002/14651858.CD007122.pub4
15. National Institute for Health and Care Excellence (NICE). Diabetes in pregnancy: management from preconception to the postnatal period. Available from: https://www.nice.org.uk/guidance/ng3
16. Ye W, Luo C, Huang J, et al. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis BMJ 2022;377:e067946. DOI: https://doi.org/10.1136/bmj-2021-067946
17. Anzaku A, Musa J. Prevalence and associated risk factors for gestational diabetes in Jos, North-Central, Nigeria. Arch Gynecol Obstet 2013;287:859-63. DOI: https://doi.org/10.1007/s00404-012-2649-z
18. Kalra P, Kachhwaha C, Singh H. Prevalence of gestational diabetes mellitus and its outcome in western Rajasthan. Indian J Endocrinol Metab 2013;17:677. DOI: https://doi.org/10.4103/2230-8210.113760
19. Mirabelli M, Tocci V, Donnici A, et al. Maternal preconception body mass index overtakes age as a risk factor for gestational diabetes mellitus. J. Clini Med 2023;12:2830. DOI: https://doi.org/10.3390/jcm12082830
20. Onyenekwe BM, Young EE, Nwatu CB, et al. Prevalence of gestational diabetes in southeast Nigeria using the updated diagnostic guidelines. Int J Diabetes Metab 2019;25:26-32. DOI: https://doi.org/10.1159/000500089
21. Dornhorst A, Williamson C. Diabetes and endocrine disease in pregnancy. Dewhurst’s Textb Obstet Gynaecol 2012;5:121-36. DOI: https://doi.org/10.1002/9781119979449.ch13
22. Pridjian G, Benjamin T. Update on gestational diabetes. Obstet Gynecol Clin North Am 2010;37:255-67. DOI: https://doi.org/10.1016/j.ogc.2010.02.017
23. Feng H, Zhu W, Yang H, et al. Relationship between oral glucose tolerance test characteristics and adverse pregnancy outcomes among women with gestational diabetes mellitus. Chin Med J (Engl) 2017;130:1012-8. DOI: https://doi.org/10.4103/0366-6999.204928
24. John P, Komal S, Rashika MR. Intermediate hyperglycemia in early pregnancy: a south Asian perspective. World J Diabetes 2023;14:573-84. DOI: https://doi.org/10.4239/wjd.v14.i5.573

How to Cite



“Prevalence and Maternal-Fetal Outcome Among Patients With Gestational Diabetes at Aminu Kano Teaching Hospital”. 2026. Pyramid Journal of Medicine 9 (1). https://doi.org/10.4081/pjm.2026.561.